Effects of estradiol on renal cyclic guanosine monophosphate and oxidative stress in spontaneously hypertensive rats

Gender Medicine

Volumn 6, Issue 3, 2009, Pages 498-510

  Sullivan, Jennifer C ^a   Pardieck, Jennifer L ^a   Brinson, Krystal ^a   Kang, Kyu Tae ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

hypertension; kidney; NADPH oxidase; NOS

Indexed keywords

CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTRADIOL; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN P22; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; BODY WEIGHT; CONTROLLED STUDY; ENZYME ACTIVITY; ESSENTIAL HYPERTENSION; FEMALE; HEART PROTECTION; HORMONE SUBSTITUTION; IN VIVO STUDY; KIDNEY CORTEX; KIDNEY FUNCTION; NONHUMAN; OVARIECTOMY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; TREATMENT OUTCOME; UTERUS WEIGHT;

ANIMALS; BIOSYNTHETIC PATHWAYS; CYCLIC GMP; ESTRADIOL; FEMALE; KIDNEY CORTEX; NADPH OXIDASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; OVARIECTOMY; OXIDATIVE STRESS; RATS; RATS, INBRED SHR; SUPEROXIDES;

EID: 70349983872     PISSN: 15508579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.genm.2009.09.003     Document Type: Article

References (61)

1. Dubey R.K., and Jackson E.K. Estrogen-induced cardiore-nal protection: Potential cellular, biochemical, and molecular mechanisms. Am J Physiol Renal Physiol. 280 (2001) F365-F388
2. Neugarten J., Acharya A., and Silbiger S.R. Effect of gender on the progression of nondiabetic renal disease: A meta-analysis. J Am Soc Nephrol. 11 (2000) 319-329
3. Silbiger S.R., and Neugarten J. The impact of gender on the progression of chronic renal disease. Am J Kidney Dis. 25 (1995) 515-533
4. Gamboa A., Shibao C., Diedrich A., et al. Contribution of endothelial nitric oxide to blood pressure in humans. Hypertension. 49 (2007) 170-177
5. Baylis C., Mitruka B., and Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest. 90 (1992) 278-281
6. Baylis C. Nitric oxide deficiency in chronic kidney disease. Am J Physiol Renal Physiol. 294 (2008) F1-F9
7. Cicinelli E., Ignarro L.J., Matteo M.G., et al. Effects of estrogen replacement therapy on plasma levels of nitric oxide in postmenopausal women. Am J Obstet Gynecol. 180 (1999) 334-339
8. Rosselli M., Imthurn B., Keller P.J., et al. Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol and norethisterone acetate. A two-year follow-up study. Hypertension. 25 (1995) 848-853
9. Best P.J., Berger P.B., Miller V.M., and Lerman A. The effect of estrogen replacement therapy on plasma nitric oxide and endothelin-1 levels in postmenopausal women. Ann Intern Med. 128 (1998) 285-288
10. Huang A., Sun D., Kaley G., and Koller A. Estrogen maintains nitric oxide synthesis in arterioles of female hypertensive rats. Hypertension. 29 (1997) 1351-1356
11. Huang A., Sun D., Kaley G., and Koller A. Estrogen preserves regulation of shear stress by nitric oxide in arterioles of female hypertensive rats. Hypertension. 31 (1998) 309-314
12. Li P., Ferrario C.M., Ganten D., and Brosnihan K.B. Chronic estrogen treatment in female transgenic (mRen2)27 hypertensive rats augments endothelium-derived nitric oxide release. Am J Hypertens. 10 (1997) 662-670
13. Brosnihan K.B., Moriguchi A., Nakamoto H., et al. Estrogen augments the contribution of nitric oxide to blood pressure regulation in transgenic hypertensive rats expressing the mouse Ren-2 gene. Am J Hypertens. 7 (1994) 576-582
14. Kone B.C., and Baylis C. Biosynthesis and homeostatic roles of nitric oxide in the normal kidney. Am J Physiol. 272 (1997) F561-F578
15. Schneider M.P., Ge Y., Pollock D.M., et al. Collecting duct-derived endothelin regulates arterial pressure and Na excretion via nitric oxide. Hypertension. 51 (2008) 1605-1610
16. Morschl E., Bretus I., Nemcsik J., et al. Estrogen-mediated up-regulation of the Ca-dependent constitutive nitric oxide synthase in the rat aorta and heart. Life Sci. 68 (2000) 49-55
17. Yang S., Bae L., and Zhang L. Estrogen increases eNOS and NOx release in human coronary artery endothelium. J Cardiovasc Pharmacol. 36 (2000) 242-247
18. Hishikawa K., Nakaki T., Marumo T., et al. Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells. FEBS Lett. 360 (1995) 291-293
19. Xiao S., Gillespie D.G., Baylis C., et al. Effects of estra-diol and its metabolites on glomerular endothelial nitric oxide synthesis and mesangial cell growth. Hypertension. 37 (2001) 645-650
20. Shibata Y., Takaoka M., Maekawa D., et al. Involvement of nitric oxide in the suppressive effect of 17beta-estradiol on endothelin-1 overproduction in is-chemic acute renal failure. J Cardiovasc Pharmacol. 44 Suppl 1 (2004) S459-S461
21. Gross M.L., Adamczak M., Rabe T., et al. Beneficial effects of estrogens on indices of renal damage in uninephrectomized SHRsp rats. J Am Soc Nephrol. 15 (2004) 348-358
22. Antus B., Hamar P., Kokeny G., et al. Estradiol is nephroprotective in the rat remnant kidney. Nephrol Dial Transplant. 18 (2003) 54-61
23. Helmersson J., Mattsson P., and Basu S. Prostaglandin F(2alpha) metabolite and F(2)-isoprostane excretion rates in migraine. Clin Sci (Lond). 102 (2002) 39-43
24. Sasser J.M., Sullivan J.C., Elmarakby A.A., et al. Reduced NOS3 phosphorylation mediates reduced NO/cGMP signaling in mesenteric arteries of deoxycorticosterone acetate-salt hypertensive rats. Hypertension. 43 (2004) 1080-1085
25. Dubey R.K., Tyurina Y.Y., Tyurin V.A., et al. Estrogen and tamoxifen metabolites protect smooth muscle cell membrane phospholipids against peroxidation and inhibit cell growth. Circ Res. 84 (1999) 229-239
26. Wassmann S., Bäumer A.T., Strehlow K., et al. Endothelial dysfunction and oxidative stress during estrogen deficiency in spontaneously hypertensive rats. Circulation. 103 (2001) 435-441
27. Sullivan J.C., Semprun-Prieto L., Boesen E.I., et al. Sex and sex hormones influence the development of albuminuria and renal macrophage infiltration in spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol. 293 (2007) R1573-R1579
28. National Institutes of Health. Guide for the Care and Use of Laboratory Animals (2001), National Academy of Sciences, Washington, DC
29. Case J., and Davison C.A. Estrogen alters relative contributions of nitric oxide and cyclooxygenase products to endothelium-dependent vasodilation. J Pharmacol Exp Ther. 291 (1999) 524-530
30. Pollock J.S., Nakane M., Förstermann U., and Murad F. Particulate and soluble bovine endothelial nitric oxide synthases are structurally similar proteins yet different from soluble brain nitric oxide syn-thase. J Cardiovasc Pharmacol. 20 Suppl 12 (1992) S50-S53
31. Sullivan J.C., Giulumian A.D., Pollock D.M., et al. Functional NOS1 in the rat mesenteric arterial bed. Am J Physiol Heart Circ Physiol. 283 (2002) H658-H663
32. Babu B.R., and Griffith O.W. N5-(1-Imino-3-butenyl)-L-ornithine. A neuronal isoform selective mechanism-based inactivator of nitric oxide synthase. J Biol Chem. 273 (1998) 8882-8889
33. Thomsen L.L., Scott J.M., Topley P., et al. Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: Studies with 1400W, a novel inhibitor. Cancer Res. 57 (1997) 3300-3304
34. Satake A., Takaoka M., Nishikawa M., et al. Protective effect of 17beta-estradiol on ischemic acute renal failure through the PI3K/Akt/eNOS pathway. Kidney Int. 73 (2008) 308-317
35. Sullivan J.C., Sasser J.M., Pollock D.M., and Pollock J.S. Sexual dimorphism in renal production of pros-tanoids in spontaneously hypertensive rats. Hypertension. 45 (2005) 406-411
36. Brophy C.M., Knoepp L., Xin J., and Pollock J.S. Functional expression of NOS1 in vascular smooth muscle. Am J Physiol Heart Circ Physiol. 278 (2000) H991-H997
37. Sullivan J.C., Sasser J.M., and Pollock J.S. Sexual dimorphism in oxidant status in spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol. 292 (2007) R764-R768
38. Maric C., Xu Q., Sandberg K., and Hinojosa-Laborde C. Age-related renal disease in female Dahl saltsensitive rats is attenuated with 17 beta-estradiol supplementation by modulating nitric oxide syn-thase expression. Gend Med. 5 (2008) 147-159
39. Neugarten J., Ding Q., Friedman A., et al. Sex hormones and renal nitric oxide synthases. J Am Soc Nephrol. 8 (1997) 1240-1246
40. Sandberg K., and Ji H. Sex and the renin angiotensin system: Implications for gender differences in the progression of kidney disease. Adv Ren Replace Ther. 10 (2003) 15-23
41. Hinojosa-Laborde C., Craig T., Zheng W., et al. Ovariectomy augments hypertension in aging female Dahl salt-sensitive rats. Hypertension. 44 (2004) 405-409
42. Maric C., Sandberg K., and Hinojosa-Laborde C. Glomerulosclerosis and tubulointerstitial fibrosis are attenuated with 17beta-estradiol in the aging Dahl salt sensitive rat. J Am Soc Nephrol. 15 (2004) 1546-1556
43. Cicinelli E., Ignarro L.J., Lograno M., et al. Acute effects of transdermal estradiol administration on plasma levels of nitric oxide in postmenopausal women. Fertil Steril. 67 (1997) 63-66
44. Yamaleyeva L.M., Gallagher P.E., Vinsant S., and Chappell M.C. Discoordinate regulation of renal nitric oxide synthase isoforms in ovariectomized mRen2.Lewis rats. Am J Physiol Regul Integr Comp Physiol. 292 (2007) R819-R826
45. Pittner J., Wolgast M., Casellas D., and Persson A.E. Increased shear stress-released NO and decreased endothelial calcium in rat isolated perfused jux-tamedullary nephrons. Kidney Int. 67 (2005) 227-236
46. Cai Z., Xin J., Pollock D.M., and Pollock J.S. Shear stressmediated NO production in inner medullary collecting duct cells. Am J Physiol Renal Physiol. 279 (2000) F270-F274
47. Haynes M.P., Sinha D., Russell K.S., et al. Membrane estrogen receptor engagement activates endothe-lial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells. Circ Res. 87 (2000) 677-682
48. Hamilton C.A., Groves S., Carswell H.V., et al. Estrogen treatment enhances nitric oxide bioavailability in normotensive but not hypertensive rats. Am J Hypertens. 19 (2006) 859-866
49. Florian M., Freiman A., and Magder S. Treatment with 17-beta-estradiol reduces superoxide production in aorta of ovariectomized rats. Steroids. 69 (2004) 779-787
50. Dantas A.P., Tostes R.C., Fortes Z.B., et al. In vivo evidence for antioxidant potential of estrogen in microvessels of female spontaneously hypertensive rats. Hypertension. 39 (2002) 405-411
51. Arnal J.F., Clamens S., Pechet C., et al. Ethinylestradiol does not enhance the expression of nitric oxide synthase in bovine endothelial cells but increases the release of bioactive nitric oxide by inhibiting superoxide anion production. Proc Natl Acad Sci U S A. 93 (1996) 4108-4113
52. Paravicini T.M., and Touyz R.M. NADPH oxidases, reactive oxygen species, and hypertension: Clinical implications and therapeutic possibilities. Diabetes Care. 31 Suppl 2 (2008) S170-S180
53. Ji H., Zheng W., Menini S., et al. Female protection in progressive renal disease is associated with estradiol attenuation of superoxide production. Gend Med. 4 (2007) 56-71
54. Ebrahimian T., He Y., Schiffrin E.L., and Touyz R.M. Differential regulation of thioredoxin and NAD(P) H oxidase by angiotensin II in male and female mice. J Hypertens. 25 (2007) 1263-1271
55. Miller A.A., Drummond G.R., Mast A.E., et al. Effect of gender on NADPH-oxidase activity, expression, and function in the cerebral circulation: Role of estrogen. Stroke. 38 (2007) 2142-2149
56. Rouhanizadeh M., Takabe W., Ai L., et al. Monitoring oxidative stress in vascular endothelial cells in response to fluid shear stress: From biochemical analyses to micro- and nanotechnologies. Methods Enzymol. 441 (2008) 111-150
57. Zalba G., Beaumont F.J., San José G., et al. Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats. Hypertension. 35 (2000) 1055-1061
58. Zhang L., Fujii S., and Kosaka H. Effect of oestrogen on reactive oxygen species production in the aortas of ovariectomized Dahl salt-sensitive rats. J Hypertens. 25 (2007) 407-414
59. Marumo T., Schini-Kerth V.B., Brandes R.P., and Busse R. Glucocorticoids inhibit superoxide anion production and p22 phox mRNA expression in human aortic smooth muscle cells. Hypertension. 32 (1998) 1083-1088
60. Benter I.F., Yousif M.H., Dhaunsi G.S., et al. Angiotensin-(1-7) prevents activation of NADPH oxidase and renal vascular dysfunction in diabetic hypertensive rats. Am J Nephrol. 28 (2008) 25-33
61. Hwang J., Rouhanizadeh M., Hamilton R.T., et al. 17beta-Estradiol reverses shear-stress-mediated low density lipoprotein modifications. Free Radic Biol Med. 41 (2006) 568-578